Development and Validation of a Postoperative Re-fracture Risk Model for Osteoporotic Spinal Fractures
NCT ID: NCT06379243
Last Updated: 2024-04-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
560 participants
INTERVENTIONAL
2023-12-01
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Construction and Validation of a Risk Prediction Model for Secondary Vertebral Fracture in Patients With Osteoporotic Vertebral Compression Fractures After Percutaneous Vertebroplasty
NCT06172179
PRevention of OsTEoporotiC FracTure 2 Pilot Study
NCT06134908
The Construction of Bidirectional Column Study of Acute Osteoporotic Vertebral Compression Fractures
NCT06586996
Height Loss, Kyphosis Indicators, Bone Mineral Density and Vertebral Fractures in Chinese Postmenopausal Women
NCT03798444
Imaging Parameters to Predict Future Vertebral Fracture in Osteoporosis
NCT01653873
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
non-operative vertebra refracture
observe non-operative vertebra refracture after PVP/PKP surgery.
PVP/PKP
PVP or PKP surgery in patients with osteoporotic vertebral compression fractures
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PVP/PKP
PVP or PKP surgery in patients with osteoporotic vertebral compression fractures
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The presence of bone marrow edema or hemorrhage (acute fracture) in the fractured vertebrae is clearly defined by MR examination, and the responsible vertebrae is treated with PVP / PKP;
* Number of fractured vertebrae: 1-3 vertebral compression fractures (including old fractures).
Exclusion Criteria
* Presence of spinal infection and malignant neoplastic disease;
* Presence of mental disease, cognitive impairment, or critical illness (e.g., severe cardiac or cerebrovascular disease).
50 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Guangzhou Medical University
OTHER
Huizhou Municipal Central Hospital
OTHER
Dongguan Hospital of Traditional Chinese Medicine
OTHER
The Seventh Affiliated Hospital of Sun Yat-sen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Qingyu Liu
chief physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
qingyu liu
Role: PRINCIPAL_INVESTIGATOR
The Seventh Affiliated Hospital of Sun Yat-sen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Seventh Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KY-2023-008-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.